{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Catatonie : Questions médicales les plus fréquentes",
"headline": "Catatonie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Catatonie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-23",
"dateModified": "2025-04-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Catatonie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Manifestations neurocomportementales",
"url": "https://questionsmedicales.fr/mesh/D019954",
"about": {
"@type": "MedicalCondition",
"name": "Manifestations neurocomportementales",
"code": {
"@type": "MedicalCode",
"code": "D019954",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F01.700"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Catatonie",
"alternateName": "Catatonia",
"code": {
"@type": "MedicalCode",
"code": "D002389",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jonathan P Rogers",
"url": "https://questionsmedicales.fr/author/Jonathan%20P%20Rogers",
"affiliation": {
"@type": "Organization",
"name": "Division of Psychiatry, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Dusan Hirjak",
"url": "https://questionsmedicales.fr/author/Dusan%20Hirjak",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. dusan.hirjak@zi-mannheim.de."
}
},
{
"@type": "Person",
"name": "Michael S Zandi",
"url": "https://questionsmedicales.fr/author/Michael%20S%20Zandi",
"affiliation": {
"@type": "Organization",
"name": "National Hospital for Neurology and Neurosurgery, London, UK, and honorary associate professor, Queen Square Institute of Neurology, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Anthony S David",
"url": "https://questionsmedicales.fr/author/Anthony%20S%20David",
"affiliation": {
"@type": "Organization",
"name": "Institute of Mental Health, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Stefan Fritze",
"url": "https://questionsmedicales.fr/author/Stefan%20Fritze",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Detection of Methicillin-Resistant Staphylococcus Aureus using vancomycin conjugated silica-based fluorescent nanoprobe.",
"datePublished": "2023-11-13",
"url": "https://questionsmedicales.fr/article/37979538",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.saa.2023.123643"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of the effectiveness of ceftobiprole and vancomycin in a rabbit model of methicillin-resistant Staphylococcus aureus induced meningitis.",
"datePublished": "2024-05-02",
"url": "https://questionsmedicales.fr/article/38697031",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000527531"
}
},
{
"@type": "ScholarlyArticle",
"name": "Resistance phenotype and genetic features of a heterogeneous vancomycin intermediate-resistant Staphylococcus aureus strain from an immunocompromised patient.",
"datePublished": "2023-12-07",
"url": "https://questionsmedicales.fr/article/38057692",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s42770-023-01192-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mechanisms of acquisition of vanA operon among vancomycin-resistant Staphylococcus aureus genomes: the tip of the iceberg?",
"datePublished": "2024-04-08",
"url": "https://questionsmedicales.fr/article/38599552",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijantimicag.2024.107154"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis.",
"datePublished": "2024-01-31",
"url": "https://questionsmedicales.fr/article/38297970",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/infdis/jiad577"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Comportement et mécanismes comportementaux",
"item": "https://questionsmedicales.fr/mesh/D001520"
},
{
"@type": "ListItem",
"position": 3,
"name": "Manifestations neurocomportementales",
"item": "https://questionsmedicales.fr/mesh/D019954"
},
{
"@type": "ListItem",
"position": 4,
"name": "Catatonie",
"item": "https://questionsmedicales.fr/mesh/D002389"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Catatonie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Catatonie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Catatonie",
"description": "Comment diagnostiquer la catatonie ?\nQuels tests sont utilisés pour la catatonie ?\nLa catatonie peut-elle être confondue avec d'autres troubles ?\nQuels critères sont utilisés pour le diagnostic ?\nLa catatonie est-elle toujours liée à des troubles mentaux ?",
"url": "https://questionsmedicales.fr/mesh/D002389?mesh_terms=Vancomycin-Resistant+Staphylococcus+aureus&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Catatonie",
"description": "Quels sont les symptômes principaux de la catatonie ?\nLa catatonie peut-elle provoquer des comportements étranges ?\nY a-t-il des symptômes émotionnels associés ?\nLa catatonie peut-elle entraîner des troubles de la conscience ?\nLes symptômes de la catatonie sont-ils constants ?",
"url": "https://questionsmedicales.fr/mesh/D002389?mesh_terms=Vancomycin-Resistant+Staphylococcus+aureus&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Catatonie",
"description": "Peut-on prévenir la catatonie ?\nQuels facteurs de stress peuvent déclencher la catatonie ?\nLa gestion des maladies mentales aide-t-elle à prévenir la catatonie ?\nLes soins de santé mentale préventifs sont-ils efficaces ?\nL'éducation sur la santé mentale peut-elle aider ?",
"url": "https://questionsmedicales.fr/mesh/D002389?mesh_terms=Vancomycin-Resistant+Staphylococcus+aureus&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Catatonie",
"description": "Quels traitements sont efficaces pour la catatonie ?\nLa psychothérapie est-elle utile pour la catatonie ?\nLes antipsychotiques sont-ils utilisés pour la catatonie ?\nCombien de temps dure le traitement de la catatonie ?\nY a-t-il des traitements non médicamenteux pour la catatonie ?",
"url": "https://questionsmedicales.fr/mesh/D002389?mesh_terms=Vancomycin-Resistant+Staphylococcus+aureus&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Catatonie",
"description": "Quelles complications peuvent survenir avec la catatonie ?\nLa catatonie peut-elle entraîner des problèmes physiques ?\nY a-t-il des risques de suicide associés à la catatonie ?\nLes complications sont-elles réversibles ?\nLa catatonie peut-elle affecter la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D002389?mesh_terms=Vancomycin-Resistant+Staphylococcus+aureus&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Catatonie",
"description": "Quels sont les facteurs de risque de la catatonie ?\nL'âge influence-t-il le risque de catatonie ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress psychologique est-il un facteur de risque ?\nLes maladies neurologiques augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D002389?mesh_terms=Vancomycin-Resistant+Staphylococcus+aureus&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la catatonie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'observation des symptômes et l'exclusion d'autres troubles."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la catatonie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des évaluations cliniques et parfois des examens d'imagerie peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "La catatonie peut-elle être confondue avec d'autres troubles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec la schizophrénie ou d'autres troubles psychotiques."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent l'immobilité, l'excitation, et des comportements stéréotypés."
}
},
{
"@type": "Question",
"name": "La catatonie est-elle toujours liée à des troubles mentaux ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle peut aussi être causée par des conditions médicales ou neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux de la catatonie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'immobilité, l'excitation, et des postures rigides."
}
},
{
"@type": "Question",
"name": "La catatonie peut-elle provoquer des comportements étranges ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des comportements tels que des mouvements répétitifs ou des grimaces peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes émotionnels associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme l'anxiété ou la dépression peuvent accompagner la catatonie."
}
},
{
"@type": "Question",
"name": "La catatonie peut-elle entraîner des troubles de la conscience ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent présenter des altérations de la conscience ou de la perception."
}
},
{
"@type": "Question",
"name": "Les symptômes de la catatonie sont-ils constants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils peuvent fluctuer et varier en intensité selon les individus."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la catatonie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un traitement précoce des troubles mentaux peut aider."
}
},
{
"@type": "Question",
"name": "Quels facteurs de stress peuvent déclencher la catatonie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des événements traumatiques ou un stress intense peuvent déclencher des épisodes de catatonie."
}
},
{
"@type": "Question",
"name": "La gestion des maladies mentales aide-t-elle à prévenir la catatonie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne gestion des maladies mentales peut réduire le risque de catatonie."
}
},
{
"@type": "Question",
"name": "Les soins de santé mentale préventifs sont-ils efficaces ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins préventifs peuvent diminuer l'incidence des troubles catatoniques."
}
},
{
"@type": "Question",
"name": "L'éducation sur la santé mentale peut-elle aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sensibiliser les individus aux troubles mentaux peut favoriser une détection précoce."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces pour la catatonie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les benzodiazépines et l'électroconvulsivothérapie."
}
},
{
"@type": "Question",
"name": "La psychothérapie est-elle utile pour la catatonie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La psychothérapie peut être bénéfique, mais elle est souvent combinée avec des médicaments."
}
},
{
"@type": "Question",
"name": "Les antipsychotiques sont-ils utilisés pour la catatonie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais leur efficacité peut varier et ils ne sont pas toujours recommandés."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement de la catatonie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie selon la gravité et la réponse du patient aux interventions."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non médicamenteux pour la catatonie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des approches comme la thérapie occupationnelle peuvent être envisagées."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la catatonie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des infections, des thromboses et des troubles nutritionnels."
}
},
{
"@type": "Question",
"name": "La catatonie peut-elle entraîner des problèmes physiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'immobilité prolongée peut causer des problèmes physiques comme des escarres."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de suicide associés à la catatonie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent avoir un risque accru de comportements suicidaires."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "La catatonie peut-elle affecter la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut gravement affecter la qualité de vie des patients et de leurs proches."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la catatonie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de troubles psychiatriques et les traumatismes sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de catatonie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la catatonie est plus fréquente chez les jeunes adultes et les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de troubles mentaux peut augmenter le risque de catatonie."
}
},
{
"@type": "Question",
"name": "Le stress psychologique est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un stress psychologique intense peut déclencher des épisodes de catatonie."
}
},
{
"@type": "Question",
"name": "Les maladies neurologiques augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies neurologiques peuvent prédisposer à la catatonie."
}
}
]
}
]
}
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a worldwide major pathogenic bacteria that has emerged over the past three decades as the leading cause of nosocomial and community-acquired infec...
Nosocomial meningitis may occur after procedures affecting the central nervous system or following traumatic injury. The causative infectious organism is commonly Staphylococcus aureus, a gram-positiv...
The strain of MRSA used was ATCC 43300. The animals were divided into three groups and infected intracisternally with MRSA. Controls received no antibiotherapy while the ceftobiprole group received 25...
There was a significant difference (p<0.05) between both treatment groups and the control animals at 24 hours (drug trough) and 73 hours (one hour after third dose) after start of treatment in terms o...
In conclusion, intravenous treatment with ceftobiprole and vancomycin appears to be equally effective in a rabbit model of MRSA meningitis....
Strain C1 was successfully isolated from an immunosuppressed patient with persistent bacteremia, who had not previously been exposed to glycopeptide antibiotics. This strain was found to be a heteroge...
Vancomycin is frequently used as a last line defence against infections due to multidrug resistant Staphylococcus aureus. A recent finding described the acquisition of vancomycin-resistant S. aureus (...
Staphylococcus aureus is the most common cause of life-threatening endovascular infections, including infective endocarditis (IE). These infections, especially when caused by methicillin-resistant str...
Herein, we investigated the role of the purine biosynthesis repressor, PurR, in virulence factor expression and vancomycin (VAN) treatment outcomes in experimental IE due to MRSA....
The PurR-mediated repression of purine biosynthesis was confirmed by enhanced purF expression and production of an intermediate purine metabolite in purR mutant strain. In addition, enhanced expressio...
These findings suggest that the purine biosynthetic pathway intersects the coordination of virulence factor expression and in vivo persistence during VAN treatment, and may represent an avenue for nov...
This study aimed to analyze the genetic characteristics of Staphylococcus aureus with reduced vancomycin susceptibility (RVS-SA). Whole-genome sequencing was performed on 27 RVS-SA clinical isolates, ...
In the medical community, antibiotics are revered as a miracle because they stop diseases brought on by pathogenic bacteria. Antibiotics have become the cornerstone of contemporary medical advancement...
To summarize the evidence on the efficacy and safety of vancomycin compared with those of alternative treatments in adult patients with methicillin-resistant Staphylococcus aureus (MRSA) infection....
PubMed, Embase, and Web of Science were searched up to December 15, 2023, for systematic reviews and meta-analyses comparing vancomycin with alternative MRSA treatments. Primary outcomes included clin...
This umbrella review included 19 studies and 71 meta-analyses (46 efficacy and 25 safety) comparing vancomycin with 10 alternative treatments across different MRSA infection types and populations. GRA...
The quality of evidence supporting the higher efficacy of alternative treatment over vancomycin for MRSA infection was not high. Given varying safety profiles and advancements in therapeutic monitorin...
Very few studies have compared the effects and side effects of vancomycin and teicoplanin in patients with methicillin-resistant Staphylococcus aureus pneumonia. This study aimed to compare the effica...
This study examined 116 patients with methicillin-resistant Staphylococcus aureus pneumonia who met the inclusion criteria and were treated with either vancomycin (n = 54) or teicoplanin (n = 62). The...
The vancomycin group presented lower clinical failure rates (25.9% vs. 61.3%, p < 0.001), discontinuation due to treatment failure (22.2% vs. 41.9%, p = 0.024), and mortality rates (3.7% vs 19.4%, p =...
Vancomycin presented favorable treatment outcomes and more side effects compared with teicoplanin, which suggests that clinicians would need to consider the efficacy and potential side effects of thes...
Staphylococcus aureus is the primary cause of skin and soft tissue infections. Its significant adaptability and the development of resistance are the main factors linked to its spread and the challeng...